45Indexed trials
mesh condition
Brain Diseases
Intelligence
Brain Diseases intelligence: 45 indexed trials, 12 recruiting studies, 44 sponsors across 41 countries.
12Recruiting
44Sponsors
41Countries
Leading sponsors
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.20 recruiting
Beats Medical10 recruiting
Danilo Toni10 recruiting
Chinese University of Hong Kong10 recruiting
Columbia University11 recruiting
Comenius University11 recruiting
Beijing Friendship Hospital10 recruiting
Eisai Co., Ltd.10 recruiting
Eisai Limited10 recruiting
Eli Lilly and Company11 recruiting
Elizabeth K Rhodus10 recruiting
Affiris AG10 recruiting
Geographic activity
United States21trials
France8trials
Canada8trials
Germany5trials
Spain5trials
Sweden4trials
South Korea4trials
United Kingdom4trials
Belgium4trials
Italy4trials
Romania3trials
Slovakia3trials
Leading interventions
E20202trials
topiramate2trials
ACI-24.060 at Dose B in Study Part 1a1trials
ACI-24.060 at Dose C in Study Part 1a1trials
ACI-24.060 at Dose C in Study Part 21trials
ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b1trials
AFFITOPE® AD021trials
ACI-24.060 with an additional adjuvant at Dose E in Study Part 1b1trials
BGG4921trials
BPN147701trials
Cedrus RB series response pad; Adtech Behnke-Fried micro-electrodes; Neuralynx or Blackrock electrophysiology system; Blackrock Cerestim or Natus Nicolet stimulator1trials
ACI-24.060 at Dose B in Study Part 21trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.